OrganiGram OGI 深 滬
已收盤 08-07 16:00:00 美东时间
0.99
0.000
0.00%
華盛通- 最 高1.02
- 今 開0.9854
- 成交量 35.64万股
- 最 低 0.97
- 昨 收 0.99
- 總市值 1.39亿
- 52周最高 2.24
- 市盈率 靜 --
- 換手率 0.25%
- 52周最低 0.8531
- 委 比 0.00%
- 總股本 1.41亿
- 歷史最高 33.76
- 量 比 1.54
- 振 幅 5.05%
- 歷史最低 0.85
- 每 手 1
- 風險率 0.30%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Organigram Global Sets August 11 Date for Q3 2026 Results
An announcement from Organigram Global ( ($TSE:OGI) ) is now available. Organig...
08-04 22:27
Organigram Maintains Cannabis Market Lead Ahead Of Q3 Results
Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH ("Sanity"), today provided a business update highlighting initial operating performance f...
07-20 18:05
Transcript: OrganiGram Holdings Q2 2026 Earnings Conference Call
OrganiGram Holdings (NASDAQ:OGI) held its second-quarter earnings conference ca...
05-13 17:10
Organigram Says Vape Weakness Pressures Margins
Organigram reports weak Q2 fiscal 2026 results due to vape and pre-roll sales decline, but expects improvement with recent acquisition, operational changes.
05-13 02:30
Organigram hits 52-week low after Q2 results
Organigram Global (OGI) lost ~15% on Tuesday to reach a new 52-week low after the Canadian cannabis company disappointed investors with its Q2 fiscal 2026 results. The Toronto-based firm reported C$59...
05-12 23:59
Organigram Global shares are trading lower after the company reported worse-than-expected Q2 sales results.
Organigram Global shares are trading lower after the company reported worse-tha...
05-12 23:56
Organigram Global FY2026 Revenue expected to be more than $350.000M vs $341.450M Est
Organigram Global (NASDAQ:OGI) FY2026 Revenue expected to be more than $350.000M vs $341.450M Est
05-12 20:18
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
OrganiGram Holdings Q2 Sales $43.597M Miss $52.060M Estimate
OrganiGram Holdings (NASDAQ:OGI) reported quarterly sales of $43.597 million which missed the analyst consensus estimate of $52.060 million by 16.26 percent. This is a 4.60 percent decrease over sales of $45.698 million
05-12 18:05
Organigram Global reports Q2 results
Organigram Global press release (OGI): Q2 Net loss was $0.9 million compared to net income of $42.5 million in Q2 Fiscal 2025. Revenue of $93.3M (-9.2% Y/Y) beats by $42.82M. Net Revenue: $59.8 milli...
05-12 18:04
